1. Home
  2. ARDX vs UNIT Comparison

ARDX vs UNIT Comparison

Compare ARDX & UNIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • UNIT
  • Stock Information
  • Founded
  • ARDX 2007
  • UNIT 2015
  • Country
  • ARDX United States
  • UNIT United States
  • Employees
  • ARDX N/A
  • UNIT N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • UNIT Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • UNIT Real Estate
  • Exchange
  • ARDX Nasdaq
  • UNIT Nasdaq
  • Market Cap
  • ARDX 1.3B
  • UNIT 1.2B
  • IPO Year
  • ARDX 2014
  • UNIT N/A
  • Fundamental
  • Price
  • ARDX $3.39
  • UNIT $4.90
  • Analyst Decision
  • ARDX Strong Buy
  • UNIT Buy
  • Analyst Count
  • ARDX 8
  • UNIT 3
  • Target Price
  • ARDX $10.19
  • UNIT $6.17
  • AVG Volume (30 Days)
  • ARDX 6.4M
  • UNIT 2.0M
  • Earning Date
  • ARDX 05-01-2025
  • UNIT 05-06-2025
  • Dividend Yield
  • ARDX N/A
  • UNIT 3.17%
  • EPS Growth
  • ARDX N/A
  • UNIT N/A
  • EPS
  • ARDX N/A
  • UNIT 0.23
  • Revenue
  • ARDX $361,706,000.00
  • UNIT $1,174,418,000.00
  • Revenue This Year
  • ARDX $15.74
  • UNIT $127.95
  • Revenue Next Year
  • ARDX $34.56
  • UNIT $39.44
  • P/E Ratio
  • ARDX N/A
  • UNIT $20.79
  • Revenue Growth
  • ARDX 127.33
  • UNIT 2.44
  • 52 Week Low
  • ARDX $3.62
  • UNIT $2.57
  • 52 Week High
  • ARDX $9.20
  • UNIT $6.31
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 28.22
  • UNIT 53.95
  • Support Level
  • ARDX $3.50
  • UNIT $4.54
  • Resistance Level
  • ARDX $3.72
  • UNIT $4.77
  • Average True Range (ATR)
  • ARDX 0.26
  • UNIT 0.19
  • MACD
  • ARDX -0.13
  • UNIT 0.02
  • Stochastic Oscillator
  • ARDX 0.63
  • UNIT 75.57

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About UNIT Uniti Group Inc.

Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.

Share on Social Networks: